Current Headlines

  1. Stainless Steel Vial Filling System Developed For Use In Vaccine Facilities
    7/17/2014

    TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, recently announced the development of a stainless steel version of the fill-it system, designed for safely dispensing biohazardous materials such as vaccine stocks.

  2. Roche And A*STAR Ink Drug Discovery Deal
    7/16/2014
    A*STAR's Bioprocessing Technology Institute (BTI) announced that it has signed into agreement with pharma giant Roche to identify new drug candidates for the treatment and early detection of cancer.
  3. Research Shows Nanoparticle Drug Delivery May Harm Brain
    7/16/2014
    While nanoparticles are being designed with the hopes of delivering drugs to target locations, new research suggests that drugs delivered to the brain through nanoparticles called micelles might be more harmful than good.
  4. FDA Accepts For Review Teva’s NDA For SABA Inhaler
    7/16/2014
    Israeli firm Teva Pharmaceuticals announced that its New Drug Application (NDA) for albuterol multi-dose dry-powder inhaler (MDPI) has been accepted for review by the U.S. Food and Drug Administration (FDA).
  5. CPhI Panel To Analyse New Industry Perspectives And Innovations Ahead Of Predictive 2014 Annual Report
    7/16/2014

    CPhI Worldwide, organised by UBM Live, has announced its full line up of confirmed expert industry panel members for 2014, building on the huge success of the CPhI annual report launched at CPhI Worldwide in October 2013.

  6. White House, WHO Commit To Global Action Plan On Antimicrobial Resistance
    7/15/2014
    The World Health Organization (WHO) issued a press release to invite contributions to its global action plan on antimicrobial resistance. The U.S. White House and other G7 nations joined the Global Action Plan on Antimicrobial Resistance (AMR GAP) in June 2014. WHO intends to present the draft global action plan to the Sixty-eighth World Health Assembly in 2015, as per the assembly’s request in 2014. WHO states, “It therefore now invites organizations, institutions, networks, civil-society groups, national authorities, and ministries to contribute to the development of the action plan by taking part in an online consultation.”
  7. Scientists ID Protein Target For E. coli Drugs
    7/15/2014
    A new study published in the journal Science identifies a protein target called MurJ, necessary to the survival of E. coli bacteria, that could be a potential target for antibiotics development.
  8. ASI – Life Sciences Launches An E-Z Deploy™ Bag Configuration
    7/15/2014

    ASI, a manufacturer of single-use bioprocess bags and equipment launches an all new E-Z Deploy™ bag configuration. The bag configuration is designed to ease the requirements of biopharmaceutical manufacturers in loading large single-use bioprocess bags into tanks and equipment.

  9. CardioCell Begins Phase 2A Trial Of itMSC In HF
    7/14/2014
    Stemedica Cell Technologies subsidiary CardioCell announced that it has initiated its Phase IIA clinical trial investigating its proprietary ischemia-tolerant mesenchymal stem cells (itMSCs) in patients with chronic heart failure (HF) with non-ischemic cardiomyopathy.
  10. USC Research Teams To Test 3,000 Drug Leads
    7/14/2014
    Three research teams from the USC Stem Cell and USC Norris Cancer Center have won a prestigious prize to test 3,000 drug candidates and/or chemicals to investigate their potential in cancer and bone fractures.
Newsletter Signup
Newsletter Signup